Inactive Instrument

AVITA Medical, Inc. Stock Other OTC

Equities

AVHHL

AU000000AVH4

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 114M 75.67M Sales 2025 * 158M 105M Capitalization 340M 226M
Net income 2024 * -67M -44.48M Net income 2025 * -35M -23.24M EV / Sales 2024 * 2.83 x
Net cash position 2024 * 17.14M 11.38M Net Debt 2025 * 7.05M 4.68M EV / Sales 2025 * 2.19 x
P/E ratio 2024 *
-5 x
P/E ratio 2025 *
-11.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.3%
More Fundamentals * Assessed data
Dynamic Chart
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
Calendar
Related indices
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW